Elham Farahmand, DDS | |
2901 Wilshire Blvd, Suite 221, Santa Monica, CA 90403-4901 | |
(310) 829-0091 | |
Not Available |
Full Name | Elham Farahmand |
---|---|
Gender | Female |
Speciality | Dentist |
Location | 2901 Wilshire Blvd, Santa Monica, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518300458 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
122300000X | Dentist | 42819 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Elham Farahmand, DDS 2901 Wilshire Blvd, Suite 221, Santa Monica, CA 90403-4901 Ph: (310) 829-0091 | Elham Farahmand, DDS 2901 Wilshire Blvd, Suite 221, Santa Monica, CA 90403-4901 Ph: (310) 829-0091 |
News Archive
Cincinnati Children's researchers report in Nature Immunology a new mechanism that controls blood cell function and several possible molecular targets for treating myelodysplasia syndromes (MDS) - a group of pre-malignant disorders in which bone marrow does not produce enough healthy blood cells.
Scientists from the Institute for Research in Biomedicine (IRB Barcelona), the Life Sciences Programme at the Barcelona Supercomputing Center (BSC) and the National Institute for Bioinformatics (INB) have published a provisional "atlas" of the dynamic behaviour of proteins in the prestigious scientific journal, Proceedings of the National Academy of Sciences.
A new analysis indicates that states' Web-based and phone-based tobacco cessation programs can help people quit smoking, but certain personal characteristics may lead individuals to prefer one type of program over the other.
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, has announced positive results from a planned interim analysis of data collected six months after dosing from its ongoing Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. At its best performing dose of 60 µg per protein / 75 µg of Matrix-M2TM adjuvant, GEN-003 demonstrated a statistically significant 58 percent reduction from baseline in the viral shedding rate (p < 0.0001), the primary endpoint of the study.
Today, Monday 30th June, 2014, Isogenica, Cambridge UK and Imperial College London secure funding from the Technology Strategy Board (TSB), the UK's innovation agency, for a £347,000 project to optimise a gene library assembly technology for potential use in synthetic biology.
› Verified 9 days ago
Dr. Jelson Jonathan Yalung, DDS Dentist Medicare: Medicare Enrolled Practice Location: 912 17th St, Santa Monica, CA 90403 Phone: 310-439-8321 | |
Dr. Mani Morshed, D.M.D, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 1244 7th St, Suite 202, Santa Monica, CA 90401 Phone: 310-393-9664 Fax: 310-458-3399 | |
Dr. Shahin Issac Bina, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 819 Princeton St, Santa Monica, CA 90403 Phone: 310-963-6322 | |
Shantel Noghrey Ramin, DDS Dentist Medicare: Medicare Enrolled Practice Location: 2903 Delaware Ave, Santa Monica, CA 90404 Phone: 818-468-8155 | |
Linda Beth Chen, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1304 15th St, Suite 311, Santa Monica, CA 90404 Phone: 310-656-8880 | |
Bella Doshi, Dentist Medicare: Not Enrolled in Medicare Practice Location: 2021 Santa Monica Blvd, Suite 500e, Santa Monica, CA 90404 Phone: 310-828-3522 Fax: 310-828-3422 | |
Dr. Ana Brightleaf, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1304 15th St, Suite 209, Santa Monica, CA 90404 Phone: 310-395-1810 Fax: 310-395-1035 |